Controlling hemorrhage during and after a cesarean section reduces significantly maternal mortality and morbidity and the present study is important for detection of the effectiveness of routinely increasing the oxytocin dose instead of using the standard dose only in preventing postpartum hemorrhage and additional use of uterotonics in the first 24 hours after cesarean section for high risk pregnancy.
- Medical disorders ie: Hypertensive diseases with pregnancy - Diabetes Mellitus - Collagen diseases - Coagulopathies - Cardiac diseases - Anemia
History of postpartum hemorrhage
Placental disorders ie: placenta previa
Infertility and ICSI
- Oxytocin Allergy
Normal uncomplicated pregnancy
Emergency cesarean section
Exhausted uterus due to trial of normal labor
Parallel
Oxytocin
Drugwill receive 10 IU oxytocin intravenous bolus over one min and infusion of 10 IU oxytocin in 500 ml of 0.9 saline over four hours.
blood loss
measure blood in suction, towels and pads
haemoglobin
by laboratory asessment
haemoglobin
by laboratory asessment
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
